Natera NTRA 深 滬
等待開盤 08-06 09:30:00 美东时间
140.12
+3.550
+2.60%
華盛通- 最 高141.45
- 今 開136.57
- 成交量 225.45万股
- 最 低 134.85
- 昨 收 136.57
- 總市值 191.96亿
- 52周最高 183.00
- 市盈率 靜 --
- 換手率 1.65%
- 52周最低 110.57
- 委 比 98.18%
- 總股本 1.37亿
- 歷史最高 183.00
- 量 比 1.74
- 振 幅 4.83%
- 歷史最低 6.52
- 每 手 1
- 風險率 19.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多How Do Investors Really Feel About Natera?
Natera's (NYSE:NTRA) short percent of float has fallen 41.44% since its last re...
08-04 21:00
美股7月涨跌榜 | 与美国政府签订大单，美国稀土公司MP月涨近85%；蔚来月涨42%
与美国政府签订大单，美国稀土公司MP月涨近85%；公司拟于2026年前推出空中出租车服务，JOBY月涨近58%；乐道L90售价超预期，蔚来月涨42%>>
08-01 19:17
Biogen's Earnings Outlook
Biogen (NASDAQ:BIIB) is gearing up to announce its quarterly earnings on Thursd...
07-30 23:01
Evercore ISI Group Initiates Coverage On Natera with Outperform Rating, Announces Price Target of $170
Evercore ISI Group analyst Daniel Markowitz initiates coverage on Natera (NASDAQ:NTRA) with a Outperform rating and announces Price Target of $170.
07-28 20:44
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance, and analyst downgrades.
07-20 22:40
Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US
Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical compa...
07-02 20:00
Here's How Much $100 Invested In Natera 10 Years Ago Would Be Worth Today
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 10.8...
06-27 07:00
Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 11.2...
06-14 06:00
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
TAIPEI, June 9, 2025 /PRNewswire/ -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today anno...
06-09 19:00
9 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
06-05 01:35
